Regulation of mast-cell and basophil function and survival by IgE

Nature Reviews Immunology

Volumn 2, Issue 10, 2002, Pages 773-786

  Kawakami, Toshiaki ^a   Galli, Stephen J ^b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR; CELL ADHESION MOLECULE; CYTOKINE; IMMUNOGLOBULIN E RECEPTOR;

ALLERGY; ASTHMA; AUTOCRINE EFFECT; BASOPHIL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELL STRUCTURE; CELL SURVIVAL; CROSS LINKING; CYTOKINE RELEASE; EFFECTOR CELL; HUMAN; IMMUNOREGULATION; MAST CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FEEDBACK SYSTEM; IMMUNOLOGY; METABOLISM; MOUSE;

ANIMALS; BASOPHILS; CELL ADHESION MOLECULES; CELL SURVIVAL; CYTOKINES; FEEDBACK; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 0036780841     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri914     Document Type: Review

References (148)

1. Kitamura, Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7, 59-76 (1989).
2. Metcalfe, D. D., Baram, D. & Mekori, Y. A. Mast cells. Physiol. Rev. 77, 1033-1079 (1997).
3. Galli, S. J. & Lantz, C. S. in Fundamental Immunology (ed. Paul, W. E.) 1137-1184 (Lippincott-Raven, Philadelphia, 1999).
4. Galli, S. J., Zsebo, K. M. & Geissler, E. N. The kit ligand, stem cell factor. Adv. Immunol. 55, 1-96 (1994).
5. Galli, S. J. Mast cells and basophils. Curr. Opin. Hematol. 7, 32-39 (2000).
6. Galli, S. J., Metcalfe, D. D. & Dvorak, A. M. in Williams Hematology (eds. Beutler, E., Lichtman, M. A., Coller, B. S., Kipps, T. J. & Seligsohn, U.) 801-815 (McGraw-Hill, New York, 2001).
7. Williams, C. M. M. & Galli, S. J. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105, 847-859 (2000).
8. Sayama, K. et al. Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11. BMC Immunol. 3, 5 (2002).
9. Metzger, H. The receptor with high affinity for IgE. Immunol. Rev. 125, 37-48 (1992).
10. Turner, H. & Kinet, J.-P. Signalling through the high-affinity IgE receptor FcεRI. Nature 402, B24-B30 (1999).
11. Wedemeyer, J., Tsai, M. & Galli, S. J. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12, 624-631 (2000).
12. Galli, S. J. Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J. Exp. Med. 186, 343-347 (1997).
13. Williams, C. M. M. & Galli, S. J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med 192, 455-462 (2000).
14. Kobayashi, T. et al. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J. Immunol. 164, 3855-3861 (2000). References 13 and 14 identify crucial roles for mast cells in the airway hyperresponsiveness (references 13 and 14) and airway inflammation (reference 13) that is induced by relatively 'weak' immunological stimulation.
15. Gauchat, J. F. et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340-343 (1993).
16. Mecheri, S. & David, B. Unravelling the mast-cell dilemma: culprit or victim of its generosity? Immunol. Today 18, 212-215 (1997).
17. Jutel, M. et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420-425 (2001).
18. Ishizaka, K. & Ishizaka, T. Identification of γE-antibodies as a carrier of reaginic activity. J. Immunol. 99, 1187-1198 (1967).
19. Johansson, S. G. O. & Bennich, H. in Gammaglobulins, Structure and Control of Biosynthesis (ed. Kilander, J.) 193-197 (Almqvist & Wiksell, Stockholm, 1967).
20. Ravetch, J. V. & Bolland, S. IgG Fc receptors. Annu. Rev. Immunol. 19, 275-290 (2001).
21. Garman, S. C., Kinet, J.-P. & Jardetzky, T. S. Crystal structure of the human high-affinity IgE receptor. Cell 95, 951-961 (1998).
22. Garman, S. C., Wurzburg, B. A., Tarchevskaya, S. S., Kinet, J.-P. & Jardetzky, T. S. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα. Nature 406, 259-266 (2000).
23. Hutchcroft, J. E., Geahlen, R. L., Deanin, G. G. & Oliver, J. M. FcεRI-mediated tyrosine phosphorylation and activation of the 72-kDa protein-tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells. Proc. Natl Acad. Sci. USA 89, 9107-9111 (1992).
24. Eiseman, E. & Bolen, J. B. Engagement of the high-affinity IgE receptor activates Src protein-related tyrosine kinases. Nature 355, 78-80 (1992).
25. Kawakami, Y. et al. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon FcεRI cross-linking. Mol. Cell. Biol. 14, 5108-5113 (1994).
26. Jouvin, M. H. et al. Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high-affinity immunoglobulin E receptor. J. Biol. Chem. 269, 5918-5925 (1994).
27. Cambier, J. C. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J. Immunol. 155, 3281-3285 (1995).
28. El-Hillal, O., Kurosaki, T., Yamamura, H., Kinet, J.-P. & Scharenberg, A. M. Syk kinase activation by a Src kinase-initiated activation loop phosphorylation chain reaction. Proc. Natl Acad. Sci. USA 94, 1919-1924 (1997).
29. Kimura, T., Sakamoto, H., Appella, E. & Siraganian, R. P. Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides. Mol. Cell. Biol. 16, 1471-1478 (1996).
30. Holowka, D., Sheets, E. D. & Baird, B. Interactions between FcεRI and lipid raft components are regulated by the actin cytoskeleton. J. Cell. Sci. 113, 1009-1019 (2000).
31. Field, K. A., Holowka, D. & Baird, B. Structural aspects of the association of FcεRI with detergent-resistant membranes. J. Biol. Chem. 274, 1753-1758 (1999).
32. Sheets, E. D., Holowka, D. & Baird, B. Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcεRI and their association with detergent-resistant membranes. J. Cell. Biol. 145, 877-887 (1999).
33. Field, K. A., Holowka, D. & Baird, B. Compartmentalized activation of the high-affinity immunoglobulin E receptor within membrane domains. J. Biol. Chem. 272, 4276-4280 (1997).
34. Field, K. A., Holowka, D. & Baird, B. FcεRI-mediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling. Proc. Natl Acad. Sci. USA 92, 9201-9205 (1995). This study, and other papers by this group, initiated the current series of studies on the role of lipid rafts in mast-cell activation and other examples of immunoreceptor-triggered cell activation.
35. Holowka, D. & Baird, B. FcεRI as a paradigm for a lipid raft-dependent receptor in hematopoietic cells. Semin. Immunol. 13, 99-105 (2001).
36. Wilson, B. S., Pfeiffer, J. R., Surviladze, Z., Gaudet, E. A. & Oliver, J. M. High-resolution mapping of mast-cell membranes reveals primary and secondary domains of FcεRI and LAT. J. Cell. Biol. 154, 645-658 (2001).
37. Wilson, B. S., Pfeiffer, J. R. & Oliver, J. M. Observing FcεRI signaling from the inside of the mast-cell membrane. J. Cell. Biol. 149, 1131-1142 (2000). This paper analyses the localization of FcεRI and signalling molecules on the mast-cell plasma membrane using electron microscopy.
38. Daeron, M. Fc receptor biology. Annu. Rev. Immunol. 15, 203-234 (1997).
39. Ott, V. L. & Cambier, J. C. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention? J. Allergy Clin. Immunol. 106, 429-440 (2000).
40. Ravetch, J. V. & Lanier, L. L. Immune inhibitory receptors. Science 290, 84-89 (2000).
41. Daeron, M. Building up the family of ITIM-bearing negative coreceptors. Immunol. Lett. 54, 73-76 (1996).
42. Malbec, O. et al. Fcε receptor I-associated Lyn-dependent phosphorylation of Fcγ receptor IIB during negative regulation of mast-cell activation. J. Immunol. 160, 1647-1658 (1998).
43. Tridandapani, S. et al. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fcγ immunoreceptor tyrosine-based inhibition motif peptide motif. Mol. Cell. Biol. 17, 4305-4311 (1997).
44. Tamir, I. et al. The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity 12, 347-358 (2000).
45. Huber, M. et al. The Src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast-cell degranulation. Proc. Natl Acad. Sci. USA 95, 11330-11335 (1998).
46. Katz, H. R. et al. Mouse mast-cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast-cell activation when coligated with the high-affinity Fc receptor for IgE. Proc. Natl Acad. Sci. USA 93, 10809-10814 (1996).
47. Lu-Kuo, J. M., Joyal, D. M., Austen, K. F. & Katz, H. R. gp49B1 inhibits IgE-initiated mast-cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of Src homology 2 domain-containing phosphatase-1 and suppression of early and late calcium mobilization. J. Biol. Chem. 274, 5791-5796 (1999).
48. Castells, M. C. et al. gp49B1-α(v)β3 interaction inhibits antigen-induced mast-cell activation. Nature Immunol. 2, 436-442 (2001).
49. Daheshia, M., Friend, D. S., Grusby, M. J., Austen, K. F. & Katz, H. R. Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J. Exp. Med. 194, 227-234 (2001).
50. Maeda, A., Kurosaki, M., Ono, M., Takai, T. & Kurosaki, T. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J. Exp. Med. 187, 1355-1360 (1998).
51. Yamashita, Y., Ono, M. & Takai, T. Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells. J. Immunol. 161, 4042-4047 (1998).
52. Blery, M. et al. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl Acad. Sci. USA 95, 2446-2451 (1998).
53. Maeda, A. et al. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1. Oncogene 18, 2291-2297 (1999).
54. Uehara, T. et al. Inhibition of IgE-mediated mast-cell activation by the paired Ig-like receptor PIR-B. J. Clin. Invest. 108, 1041-1050 (2001).
55. Guthmann, M. D., Tal, M. & Pecht, I. A secretion-inhibitory signal-transduction molecule on mast cells is another C-type lectin. Proc. Natl Acad. Sci. USA 92, 9397-9401 (1995).
56. Ortega, E., Schneider, H. & Pecht, I. Possible interactions between the Fcε receptor and a novel mast-cell function-associated antigen. Int. Immunol. 3, 333-342 (1991).
57. Song, J., Hagen, G. M., Roess, D. A., Pecht, I. & Barisas, B. G. The mast-cell function-associated antigen and its interactions with the type I Fcε receptor. Biochemistry 41, 881-889 (2002).
58. Jurgens, L., Arndt-Jovin, D., Pecht, I. & Jovin, T. M. Proximity relationships between the type I receptor for Fcε (FcεRI) and the mast-cell function-associated antigen (MAFA) studied by donor photobleaching fluorescence resonance energy transfer microscopy. Eur. J. Immunol. 26, 84-91 (1996).
59. Xu, R., Abramson, J., Fridkin, M. & Pecht, I. SH2 domain-containing inositol polyphosphate 5′-phosphatase is the main mediator of the inhibitory action of the mast-cell function-associated antigen. J. Immunol. 167, 6394-6402 (2001).
60. Xu, R. & Pecht, I. The protein tyrosine kinase Syk activity is reduced by clustering the mast-cell function-associated antigen. Eur. J. Immunol. 31, 1571-1581 (2001).
61. Conroy, M. C., Adkinson, N. F. Jr & Lichtenstein, L. M. Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release. J. Immunol. 118, 1317-1321 (1977).
62. Stallman, P. J., Aalberse, R. C., Bruhl, P. C. & van Elven, E. H. Experiments on the passive sensitization of human basophils, using quantitative immunofluorescence microscopy. Int. Arch. Allergy Appl. Immunol. 54, 364-373 (1977).
63. Malveaux, F. J., Conroy, M. C., Adkinson, N. F. Jr & Lichtenstein, L. M. IgE receptors on human basophils. Relationship to serum IgE concentration. J. Opin. Invest. 62, 176-181 (1978).
64. Furuichi, K., Rivera, J. & Isersky, C. The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression. Proc. Natl Acad. Sci. USA 82, 1522-1525 (1985).
65. Quarto, R., Kinet, J.-P. & Metzger, H. Coordinate synthesis and degradation of the α-, β- and γ-subunits of the receptor for immunoglobulin E. Mol. Immunol. 22, 1045-1051 (1985).
66. Hsu, C. & MacGlashan, D. Jr. IgE antibody up-regulates high-affinity IgE binding on murine bone-marrow-derived mast cells. Immunol. Lett. 52, 129-134 (1996).
67. Yamaguchi, M. et al. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J. Exp. Med. 185, 663-672 (1997).
68. Yano, K. et al. Production of macrophage inflammatory protein-1α by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast-cell IgE-binding ability. Lab. Invest. 77, 185-193 (1997). References 66-68 describe IgE-dependent enhancement of FcεRI cell-surface expression and its functional relevance to antigen-dependent mast-cell activation. An IgE-initiated positive-feedback mechanism (FIG. 3) is also proposed (references 67 and 68).
69. Lantz, C. S. et al. IgE regulates mouse basophil FcεRI expression in vivo. J. Immunol. 158, 2517-2521 (1997).
70. Yamaguchi, M. et al. IgE enhances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord-blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fcε receptor I expression and mediator release. J. Immunol. 162, 5455-5465 (1999).
71. Toru, H., Pawankar, R., Ra, C., Yata, J. & Nakahata, T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J. Allergy Clin. Immunol. 102, 491-502 (1998).
72. Borkowski, T. A., Jouvin, M. H., Lin, S. Y. & Kinet, J.-P. Minimal requirements for IgE-mediated regulation of surface FcεRI. J. Immunol. 167, 1290-1296 (2001).
73. Kubo, S. et al. Drastic up-regulation of FcεRI on mast cells is induced by IgE binding through stabilization and accumulation of FcεRI on the cell surface. J. Immunol. 167, 3427-3434 (2001).
74. Asai, K. et al. Regulation of mast-cell survival by IgE. Immunity 14, 791-800 (2001).
75. Kalesnikoff, J. et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14, 801-811 (2001). References 74 and 75 describe the ability of monomeric IgE to enhance mast-cell survival.
76. Huang, C., Sali, A. & Stevens, R. L. Regulation and function of mast-cell proteases in inflammation. J. Clin. Immunol. 18, 169-183 (1998).
77. Rodewald, H.-R., Dessing, M., Dvorak, A. M. & Galli, S. J. Identification of a committed precursor for the mast-cell lineage. Science 271, 818-822 (1996).
78. Lantz, C. S. et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392, 90-93 (1998).
79. Li, L., Zhang, X.-T. & Krilis, S. A. in Signal Transduction in Mast Cells and Basophils (eds Razin, E. & Rivera, J.) 54-65 (Springer-Verlag, New York, 1998).
80. Mekori, Y. A., Hartmann, K. & Metcalfe, D. D. in Signal transduction in Mast Cells and Basophils (eds Razin, E. & Rivera, J.) 85-94 (Springer-Verlag, New York, 1998).
81. Mekori, Y. A., Oh, C. K. & Metcalfe, D. D. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J. Immunol. 151, 3775-3784 (1993).
82. Yee, N. S., Paek, I. & Besmer, P. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. J. Exp. Med. 179, 1777-1787 (1994).
83. Iemura, A., Tsai, M., Ando, A., Wershil, B. K. & Galli, S. J. The c-kit ligand, stem-cell factor, promotes mast-cell survival by suppressing apoptosis. Am. J. Pathol. 144, 321-328 (1994).
84. Plaut, M. et al. Mast-cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature 339, 64-67 (1989).
85. Tsai, M., Tam, S. Y. & Galli, S. J. Distinct patterns of early response gene expression and proliferation in mouse mast cells stimulated by stem-cell factor, interleukin-3, or IgE and antigen. Eur. J. Immunol. 23, 867-872 (1993).
86. Tsai, M., Chen, R. H., Tam, S. Y., Blenis, J. & Galli, S. J. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or FcεRI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur. J. Immunol. 23, 3286-3291 (1993).
87. Yoshikawa, H., Nakajima, Y. & Tasaka, K. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J. Immunol. 162, 6162-6170 (1999).
88. Xiang, Z. et al. Essential role of the prosurvival bcl-2 homologue A1 in mast-cell survival after allergic activation. J. Exp. Med. 194, 1561-1569 (2001). References 87 and 88 identify the ability of FcεRI aggregation to enhance mast-cell survival.
89. Yeatman, C. F. 2nd et al. Combined stimulation with the T-helper cell type-2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast-cell apoptosis. J. Exp. Med. 192, 1093-1103 (2000).
90. de Andres, B. et al. FcγRII (CD32) is linked to apoptotic pathways in murine granulocyte precursors and mature eosinophils. Blood 90, 1267-1274 (1997).
91. Kim, J. T., Schimming, A. W. & Kita, H. Ligation of FcγRII (CD32) pivotally regulates survival of human eosinophils. J. Immunol. 162, 4253-4259 (1999).
92. Gamberale, R., Giordano, M., Trevani, A. S., Andonegul, G. & Geffner, J. R. Modulation of human neutrophil apoptosis by immune complexes. J. Immunol. 161, 3666-3674 (1998).
93. Azzoni, L., Anegon, I., Calabretta, B. & Perussia, B. Ligand binding to FcγR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J. Immunol. 154, 491-499 (1995).
94. Ortaldo, J. R., Mason, A. T. & O'Shea, J. J. Receptor-induced death in human natural killer cells: involvement of CD16. J. Exp. Med. 181, 339-344 (1995).
95. Thompson, H. L., Burbelo, P. D., Segui-Real, B., Yamada, Y. & Metcalfe, D. D. Laminin promotes mast-cell attachment. J. Immunol. 143, 2323-2327 (1989).
96. Dastych, J., Costa, J. J., Thompson, H. L. & Metcalfe, D. D. Mast-cell adhesion to fibronectin. Immunology 73, 478-484 (1991).
97. Bianchine, P. J., Burd, P. R. & Metcalfe, D. D. IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell-surface vitronectin receptors. J. Immunol. 149, 3665-3671 (1992).
98. Adachi, S. et al. Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. Blood 79, 650-656 (1992).
99. Adachi, S. et al. Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem-cell factor. Exp. Hematol. 23, 58-65 (1995).
100. d anemic mice. Blood 53, 492-497 (1979).
101. Serve, H. et al. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 14, 473-483 (1995).
102. Kinashi, T., Escobedo, J. A., Williams, L. T., Takatsu, K. & Springer, T. A. Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase Cγ1 pathways. Blood 86, 2086-2090 (1995).
103. Galli, S. J., Gordon, J. R. & Wershil, B. K. Cytokine production by mast cells and basophils. Curr. Opin. Immunol. 3, 865-872 (1991).
104. Galli, S. J. & Costa, J. J. Mast-cell-leukocyte cytokine cascades in allergic inflammation. Allergy 50, 851-862 (1995).
105. Wegelie-Steffen, A. L., Hartmann, K., Vliagoftis, H. & Metcalfe, D. D. Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells. Immunology 94, 569-574 (1998).
106. Hartmann, K., Wagelie-Steffen, A. L., von Stebut, E. & Metcalfe, D. D. Fas (CD95, APO-1) antigen expression and function in murine mast cells. J. Immunol. 159, 4006-4014 (1997).
107. Piliponsky, A. M. & Levi-Schaffer, F. Regulation of apoptosis in mast cells. Apoptosis 5, 435-441 (2000).
108. Datta, S. R. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241 (1997).
109. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R. & Nunez, G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689 (1997).
110. Cardone, M. H. et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321 (1998).
111. del Peso, L., Gonzalez, V. M., Hernandez, R., Barr, F. G. & Nunez, G. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 18, 7328-7333 (1999).
112. Tang, E. D., Nunez, G., Barr, F. G. & Guan, K. L. Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274, 16741-16746 (1999).
113. Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868 (1999).
114. Liu, Q. et al. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid-cell survival. Genes Dev. 13, 786-791 (1999).
115. Kawakami, Y. et al. Regulation of protein kinase Cβl by two protein-tyrosine kinases, Btk and Syk. Proc. Natl Acad. Sci. USA 97, 7423-7428 (2000).
116. Kawakami, Y. et al. Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc. Natl Acad. Sci. USA 94, 3938-3942 (1997).
117. Kawakami, Y., Hartman, S. E., Holland, P. M., Cooper, J. A. & Kawakami, T. Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C and JNK kinases, SEK1 and MKK7. J. Immunol. 161, 1795-1802 (1998).
118. Petro, J. B., Rahman, S. M., Ballard, D. W. & Khan, W. N. Bruton's tyrosine kinase is required for activation of IκB kinase and nuclear factor-κB in response to B-cell receptor engagement. J. Exp. Med. 191, 1745-1754 (2000).
119. Bajpai, U. D., Zhang, K., Teutsch, M., Sen, R. & Wortis, H. H. Bruton's tyrosine kinase links the B-cell receptor to nuclear factor-κB activation. J. Exp. Med. 191, 1735-1744 (2000).
120. Petro, J. B. & Khan, W. N. Phospholipase Cγ2 couples Bruton's tyrosine kinase to the NF-κB signaling pathway in B lymphocytes. J. Biol. Chem. 276, 1715-1719 (2001).
121. L expression while mediating survival and actin function in primary mast cells. Immunity 12, 557-568 (2000).
122. Lu-Kuo, J. M., Fruman, D. A., Joyal, D. M., Cantley, L. C. & Katz, H. R. Impaired kit-but not FCεRI-initiated mast-cell activation in the absence of phosphoinositide 3-kinase p85α gene products. J. Biol. Chem. 275, 6022-6029 (2000).
123. Crabtree, G. R. Calcium, calcineurin and the control of transcription. J. Biol. Chem. 276, 2313-2316 (2001).
124. Sperr, W. R. et al. Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cells. J. Allergy Clin. Immunol. 98, 389-399 (1996).
125. Maurer, M. et al. A role for Bax in the regulation of apoptosis in mouse mast cells. J. Invest. Dermatol. 114, 1205-1206 (2000).
126. Mekori, Y. A. et al. Characterization of a mast cell line that lacks the extracellular domain of membrane c-kit. Immunology 90, 518-525 (1997).
127. MacGlashan, D. W. Jr et al. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J. Immunol. 158, 1438-1445 (1997).
128. Gilchrest, H. et al. Human cord-blood-derived mast cells (CBMCs) secrete proinflammatory chemokines and cytokines in response to activation of FcεRI by IgE/anti-IgE and also by IgE alone. FASEB J. 16, A1241 (2002).
129. Oettgen, H. C. et al. Active anaphylaxis in IgE-deficient mice. Nature 370, 367-370 (1994).
130. Matsuoka, K. et al. Establishment of antigen-specific IgE-transgenic mice to study pathological and immunobiological roles of IgE in vivo. Int. Immunol. 11, 987-994 (1999).
131. Dvorak, A. M., Monahan, R. A., Osage, J. E. & Dickersin, G. R. Crohn's disease: transmission electron microscopic studies II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils and the microvasculature. Hum. Pathol. 11, 606-619 (1980).
132. Weller, P. F., Tsai, M. & Galli, S. J. in Blood: Principles & Practice of Hematology 2nd edn. (eds Handin, R. I., Lux, S. E. & Stosel, T. P.) (JB Lippincott Co., Philadelphia) (in the press).
133. Li, L. et al. Identification of basophilic cells that express mast-cell granule proteases in the peripheral blood of asthma, allergy and drug-reactive patients. J. Immunol. 161, 5079-5086 (1998).
134. Kinet, J. P. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17, 931-972 (1999).
135. Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190 (2001).
136. Lemmon, M. A. & Ferguson, K. M. Pleckstrin-homology domains. Curr. Top. Microbiol. Immunol. 228, 39-74 (1998).
137. Hemmings, B. A. Akt signaling: linking membrane events to life and death decisions. Science 275, 628-630 (1997).
138. Downward, J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell. Biol. 10, 262-267 (1998).
139. Rawlings, D. J. et al. Activation of BTK by a phosphorylation mechanism initiated by SRC-family kinases. Science 271, 822-825 (1996).
140. Park, H. et al. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4, 515-525 (1996).
141. Kurosaki, T. & Kurosaki, M. Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B-cell antigen receptor function. J. Biol. Chem. 272, 15595-15598 (1997).
142. 3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17, 1961-1972 (1998).
143. 2+ following B-cell receptor activation. EMBO J. 17, 1973-1985 (1998).
144. Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P. & Samelson, L. E. LAT. the ZAP-70 tyrosine kinase substrate that links T-cell receptor to cellular activation. Cell 92, 83-92 (1998).
145. Saitoh, S. et al. LAT is essential for FcεRI-mediated mast-cell activation. Immunity 12, 525-535 (2000).
146. Tuosto, L., Michel, F. & Acuto, O. p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med. 184, 1161-1166 (1996).
147. Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S. & Bustelo, X. R. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385, 169-172 (1997).
148. Liu, S. K., Fang, N., Koretzky, G. A. & McGlade, C. J. The hematopoietic-specific adaptor protein GADS functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Curr. Biol. 9, 67-75 (1999).